Cargando…

Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes

OBJECTIVE—Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mäkinen, Ville-Petteri, Forsblom, Carol, Thorn, Lena M., Wadén, Johan, Gordin, Daniel, Heikkilä, Outi, Hietala, Kustaa, Kyllönen, Laura, Kytö, Janne, Rosengård-Bärlund, Milla, Saraheimo, Markku, Tolonen, Nina, Parkkonen, Maija, Kaski, Kimmo, Ala-Korpela, Mika, Groop, Per-Henrik
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518500/
https://www.ncbi.nlm.nih.gov/pubmed/18544706
http://dx.doi.org/10.2337/db08-0332
_version_ 1782158578830802944
author Mäkinen, Ville-Petteri
Forsblom, Carol
Thorn, Lena M.
Wadén, Johan
Gordin, Daniel
Heikkilä, Outi
Hietala, Kustaa
Kyllönen, Laura
Kytö, Janne
Rosengård-Bärlund, Milla
Saraheimo, Markku
Tolonen, Nina
Parkkonen, Maija
Kaski, Kimmo
Ala-Korpela, Mika
Groop, Per-Henrik
author_facet Mäkinen, Ville-Petteri
Forsblom, Carol
Thorn, Lena M.
Wadén, Johan
Gordin, Daniel
Heikkilä, Outi
Hietala, Kustaa
Kyllönen, Laura
Kytö, Janne
Rosengård-Bärlund, Milla
Saraheimo, Markku
Tolonen, Nina
Parkkonen, Maija
Kaski, Kimmo
Ala-Korpela, Mika
Groop, Per-Henrik
author_sort Mäkinen, Ville-Petteri
collection PubMed
description OBJECTIVE—Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, the goal was to reveal previously undetected association patterns between clinical diagnoses and biochemistry in the FinnDiane dataset. RESEARCH DESIGN AND METHODS—At baseline, clinical records, serum, and 24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes were collected. The data were analyzed by the self-organizing map, which is an unsupervised pattern recognition algorithm that produces a two-dimensional layout of the patients based on their multivariate biochemical profiles. At follow-up, the results were compared against all-cause mortality during 6.5 years (295 deaths). RESULTS—The highest mortality was associated with advanced kidney disease. Other risk factors included 1) a profile of insulin resistance, abdominal obesity, high cholesterol, triglycerides, and low HDL(2) cholesterol, and 2) high adiponectin and high LDL cholesterol for older patients. The highest population-adjusted risk of death was 10.1-fold (95% CI 7.3–13.1) for men and 10.7-fold (7.9–13.7) for women. Nonsignificant risk was observed for a profile with good glycemic control and high HDL(2) cholesterol and for a low cholesterol profile with a short diabetes duration. CONCLUSIONS—The self-organizing map analysis enabled detailed risk estimates, described the associations between known risk factors and complications, and uncovered statistical patterns difficult to detect by classical methods. The results also suggest that diabetes per se, without an adverse metabolic phenotype, does not contribute to increased mortality.
format Text
id pubmed-2518500
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-25185002009-09-01 Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes Mäkinen, Ville-Petteri Forsblom, Carol Thorn, Lena M. Wadén, Johan Gordin, Daniel Heikkilä, Outi Hietala, Kustaa Kyllönen, Laura Kytö, Janne Rosengård-Bärlund, Milla Saraheimo, Markku Tolonen, Nina Parkkonen, Maija Kaski, Kimmo Ala-Korpela, Mika Groop, Per-Henrik Diabetes Complications OBJECTIVE—Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, the goal was to reveal previously undetected association patterns between clinical diagnoses and biochemistry in the FinnDiane dataset. RESEARCH DESIGN AND METHODS—At baseline, clinical records, serum, and 24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes were collected. The data were analyzed by the self-organizing map, which is an unsupervised pattern recognition algorithm that produces a two-dimensional layout of the patients based on their multivariate biochemical profiles. At follow-up, the results were compared against all-cause mortality during 6.5 years (295 deaths). RESULTS—The highest mortality was associated with advanced kidney disease. Other risk factors included 1) a profile of insulin resistance, abdominal obesity, high cholesterol, triglycerides, and low HDL(2) cholesterol, and 2) high adiponectin and high LDL cholesterol for older patients. The highest population-adjusted risk of death was 10.1-fold (95% CI 7.3–13.1) for men and 10.7-fold (7.9–13.7) for women. Nonsignificant risk was observed for a profile with good glycemic control and high HDL(2) cholesterol and for a low cholesterol profile with a short diabetes duration. CONCLUSIONS—The self-organizing map analysis enabled detailed risk estimates, described the associations between known risk factors and complications, and uncovered statistical patterns difficult to detect by classical methods. The results also suggest that diabetes per se, without an adverse metabolic phenotype, does not contribute to increased mortality. American Diabetes Association 2008-09 /pmc/articles/PMC2518500/ /pubmed/18544706 http://dx.doi.org/10.2337/db08-0332 Text en Copyright © 2008, American Diabetes Association https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Complications
Mäkinen, Ville-Petteri
Forsblom, Carol
Thorn, Lena M.
Wadén, Johan
Gordin, Daniel
Heikkilä, Outi
Hietala, Kustaa
Kyllönen, Laura
Kytö, Janne
Rosengård-Bärlund, Milla
Saraheimo, Markku
Tolonen, Nina
Parkkonen, Maija
Kaski, Kimmo
Ala-Korpela, Mika
Groop, Per-Henrik
Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
title Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
title_full Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
title_fullStr Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
title_full_unstemmed Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
title_short Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
title_sort metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes
topic Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518500/
https://www.ncbi.nlm.nih.gov/pubmed/18544706
http://dx.doi.org/10.2337/db08-0332
work_keys_str_mv AT makinenvillepetteri metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT forsblomcarol metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT thornlenam metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT wadenjohan metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT gordindaniel metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT heikkilaouti metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT hietalakustaa metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT kyllonenlaura metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT kytojanne metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT rosengardbarlundmilla metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT saraheimomarkku metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT tolonennina metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT parkkonenmaija metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT kaskikimmo metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT alakorpelamika metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT groopperhenrik metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes
AT metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes